Sculptor Capital’s Gossamer Bio GOSS Stock Holding History

Sculptor Capital’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,425	Closed	-$137K	–	435
2023 Q2	$137K	Hold	1,425	–	–	﹤0.01%	249
2023 Q1	$144K	Buy	+1,425	New	+$218K	﹤0.01%	298

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Sculptor Capital's GOSS Position: Q3 2023 in Review

Sculptor Capital sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 1,425 shares — an estimated $137K sold.

Sculptor Capital first reported a position in GOSS in Q1 2023 and held it in 2 quarters. The position peaked at $144K in Q1 2023. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

Sculptor Capital reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
Sculptor Capital sold 1,425 Gossamer Bio shares in Q3 2023, an estimated $137K.
Sculptor Capital first reported a position in Gossamer Bio in Q1 2023 and held it in 2 quarters.
Sculptor Capital's Gossamer Bio position peaked at $144K in Q1 2023.
94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Sculptor Capital's 13F filing for Q3 2023, filed 14 Nov 2023.